Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New York State Medicaid recently removed prior authorization requirements for new hep C patients, increasing opportunities for individuals.
A daily dose of the growth factor analogue administered over 24 weeks also aided in NASH resolution.
New report highlights cancer’s toll on racial and ethnic minorities and other underserved populations.
The Cuisine for a Cause culinary experience will bring two seasoned top chefs into your kitchen.
People with an opioid use disorder, in particular, had a tenfold higher risk of being diagnosed with COVID-19.
Using a two-part testing plan could help identify those with advanced liver fibrosis among people with type 2 diabetes.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
A study underway of 300 adults hopes to answer that question within six months to one year.
Age, underlying medical conditions, race/ethnicity and economic status all play a role in determining the risk for severe illness.
A new CDC study leaves the question of indoor versus outdoor dining unanswered.
A recent study in Boston found that only 6% of people at detox centers who tested positive for either virus received follow-up medical care.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.